Feasibility and comparability of different platelet function tests in acute stroke with or without prior antiplatelet therapy.

"Conflict of interest JS has received travel reimbursements by Bayer AG outside of the submitted work. FB reports personal fees and grants from AstraZeneca, Bristol-Myers Squibb (BMS), Boehringer, Laerdal and Stryker. WM reports institutional grants or contracts from Bayer, Novo Nordisk and Pfizer; Consulting fees from Bayer, Biomarin, CSL Behring, Chugai, Freeline, LFB, Novo Nordisk, Octapharma, Pfizer, Roche, Sanofi, Sigilon, Sobi, Takeda/Shire and uniQure; Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Bayer, Biomarin, Biotest, CSL Behring, Chugai, Freeline, LFB, Novo Nordisk, Octapharma, Pfizer, Roche, Sanofi, Sigilon, sobi, Takeda/Shire, uniQure; Support for attending meetings and/or travel from Bayer, Biomarin, Biotest, CSL Behring, Chugai, LFB, Novo Nordisk, Octapharma, Pfizer, Roche, sobi, Takeda/Shire and uniQure and Participation on a Data Safety Monitoring Board or Advisory Board with Octapharma. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."

"The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This study was supported by the junior scientist program of the Goethe University Frankfurt/Faculty of Medicine (research grant to JS)."

"The study was conducted in accordance with the Declaration of Helsinki and approved by the local Ethics Committee of the Goethe University Frankfurt (2022-989). Written informed consent was provided by all patients before enrolment. The study was registered in the German Clinical Trials Register (ID DRKS00030574; https://www.drks.de)."